Heshui Wu

机构：Union Hospital, Hubei Provincial Center for Disease Control and Prevention, Institute of Predictive and Personalized Medicine of Cancer, Union Hospital, Huazhong University of Science and Technology, Hubei University

发表论文 9 篇 · 总被引 66 次 · h-index 5

代表论文

• Interpretable machine learning model for predicting early recurrence of pancreatic cancer: integrating intratumoral and peritumoral radiomics with body composition (2025 · International Journal of Surgery · 被引 16)
• A phase 1/2 study of LM-302, an anti-claudin 18.2 (CLDN18.2) antibody-drug conjugate in patients with advanced gastric/gastroesophageal junction cancer. (2024 · Journal of Clinical Oncology · 被引 16)
• A first-in-human phase I/II study of GFH375, a highly selective and potent oral KRAS G12D inhibitor in patients with KRAS G12D mutant advanced solid tumors. (2025 · Journal of Clinical Oncology · 被引 14)
• Overexpression of membrane-type 2 matrix metalloproteinase induced by hypoxia-inducible factor-1α in pancreatic cancer: Implications for tumor progression and prognosis (2014 · Molecular and Clinical Oncology · 被引 11)
• HDAC5 deficiency induces intrinsic resistance to KRAS inhibition by disrupting c-Myc acetylation-ubiquitination homeostasis (2025 · Journal of Clinical Investigation · 被引 6)
• Prognostic value of body composition on early recurrence and long-term survival of resectable pancreatic ductal adenocarcinoma (2025 · European Radiology · 被引 4)